Literature DB >> 3420620

Substrate preference of a cytosolic aldehyde dehydrogenase inducible in rat liver by treatment with 3-methylcholanthrene.

M Marselos1, R Lindahl.   

Abstract

The substrate preference of an aldehyde dehydrogenase induced in rat liver cytosol by 3-methylcholanthrene was examined. This enzyme, T-ALDH, is identical to the aldehyde dehydrogenase inducible in rat liver by 2,3,7,8-tetrachloro-dibenzo-p-dioxin and the tumor-associated aldehyde dehydrogenase found in rat hepatocellular neoplasms. With either NAD or NADP as coenzyme, the preferred substrates were the aliphatic aldehydes n-hexanal, n-nonanal, and isobutyraldehyde and the aromatic aldehydes 2,5-dihydroxybenzaldehyde, benzaldehyde, and 3-hydroxybenzaldehyde. The results indicate that T-ALDH may play a role in oxidizing a variety of aldehydes produced in physiological lipid metabolism. On the contrary, this isozyme does not seem to participate in the oxidation of small aliphatic aldehydes generated during lipid peroxidation. Similarly, no significant activity could be detected when the enzyme was tested with aldehydes produced in carbohydrate, amino acid, polyamine, steroid, and vitamin metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3420620     DOI: 10.1016/0041-008x(88)90170-6

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  3 in total

1.  N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes.

Authors:  Cynthia A Morgan; Bibek Parajuli; Cameron D Buchman; Karl Dria; Thomas D Hurley
Journal:  Chem Biol Interact       Date:  2014-12-12       Impact factor: 5.192

2.  Zoxazolamine-induced paralysis in two rat substrains: differences in hepatic drug metabolism.

Authors:  P Pappas; P Stephanou; V Vasiliou; M Marselos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.569

3.  Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.

Authors:  Byung Soo Kong; Soo Jung Im; Yang Jong Lee; Yoon Hee Cho; Yu Ri Do; Jung Woo Byun; Cheol Ryong Ku; Eun Jig Lee
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.